Butterfly iQ+ packs 9,000 sensors on a semiconductor chip, delivering whole-body imaging for under $2,000 with FDA clearance across 13 clinical applications.
Photo source:
Butterfly iQ+
Traditional ultrasound systems occupy entire rooms. Cart-based machines
weighing hundreds of pounds cost anywhere from $20,000 to over $200,000.
Hospitals dedicate specific spaces for imaging departments. Patients travel to
equipment rather than equipment reaching patients. Rural clinics cannot justify
these investments for occasional diagnostic needs. Two-thirds of the world's
population lacks access to medical imaging entirely. Butterfly Network founder
Dr. Jonathan Rothberg recognized this accessibility crisis. His solution
involved semiconductor manufacturing—the same technology powering smartphones.
The handheld ultrasound device approach replaces traditional
piezoelectric crystal transducers with capacitive micromachined ultrasonic
transducers built directly onto silicon chips. This fundamental shift enables
production at consumer electronics scale rather than specialized medical
equipment volumes.
The ultrasound on chip technology contains nearly 10,000
individual sensors on one semiconductor wafer. Traditional systems costing one
hundred times more contain merely 200 to 250 sensors. More sensors mean better
image resolution and diagnostic capability. The Butterfly iQ+ connects via
cable to iPhones or Android devices running specialized software. October 2017
brought FDA 510(k) clearance covering 13 clinical applications—the broadest
clearance ever granted for a single ultrasound transducer. These applications
span cardiac, lung, abdominal, bladder, ophthalmic, and vascular imaging. CE
Mark approval followed in April 2019, opening European, UK, Australian, and New
Zealand markets. Health Canada cleared the device in March 2020. The iQ+
represents the second generation, launched in 2020 after the original iQ
debuted commercially in 2018.
Conventional ultrasound requires swapping different probes for different body parts. Cardiac imaging needs one transducer. Abdominal scans require another. Vascular studies demand a third. Each probe costs thousands of dollars. The Butterfly system uses semiconductor architecture to electronically mimic multiple frequency ranges within a single physical probe. This eliminates probe switching during examinations. Clinicians scan hearts, lungs, abdomen, and blood vessels without changing equipment. The portable medical imaging capability fits into white coat pockets.
Physicians carry diagnostic imaging
everywhere—emergency rooms, intensive care units, ambulances, rural clinics,
and disaster zones. Battery operation removes dependence on wall power.
HIPAA-compliant cloud storage enables image sharing among care teams.
Integration with hospital medical record systems maintains workflow continuity.
August 2021 brought strategic collaboration with Caption Health, an artificial intelligence software developer. This partnership added comprehensive guidance solutions to the Butterfly platform. The point of care ultrasound software includes Auto B-line detection for lung assessments.
TeleGuidance built directly into the mobile application enables remote mentoring. Experienced sonographers guide less experienced users through complex examinations in real-time. Deep learning models improve continuously as more physicians use the devices. Neural networks train on anonymized scan data, enhancing both image acquisition assistance and interpretation accuracy.
The
system helps position probes correctly, optimize imaging parameters, and
identify anatomical structures. January 2024 brought FDA clearance for
Butterfly iQ3—the third generation featuring double the data processing speed,
enhanced resolution, and new automated imaging modes including iQ Slice and iQ
Fan for advanced 3D capabilities.
Please subscribe to have unlimited access to our innovations.